SFI Health™ EMEA Announces the Launch in Portugal of Equazen® Food Supplements, the Brand Developed to Support Cognitive Needs
SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, is excited to announce that Equazen® products will soon be available in Portugal. The company specializes in clinically researched products in microbiome, cognition, and well-being.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226258206/en/
Discover Equazen®, a science-based food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages. (Graphic: Business Wire)
This marks a significant step forward in SFI Health™ EMEA's ongoing European expansion, following the exclusive license-in agreement signed in February 2024 with Eqyon Healthcare Solutions, a local distributor specialized in healthcare products. Under the terms of the agreement, Eqyon will use its sales and marketing expertise to distribute Equazen® range in pharmacies and parapharmacies.
Equazen® is a trusted global brand offering science-based nutritional solutions to support brain health and cognitive function. Equazen® products feature a unique combination of essential fatty acids (Omega 3 and Omega 6), proven in over 15 clinical studies to support learning, concentration, and healthy brain development.
Matthew Brabazon, GM of SFI Health™ EMEA commented: “We are excited to offer our science-backed Equazen® solutions to Portuguese consumers, who are becoming more proactive in supporting their cognitive needs. Our entry in Portugal is another step of our development plan to grow in the region by widening our partners network and customer base.”
Mr. Nuno Carvalho, CEO of Eqyon, added: “We believe Equazen® products will make a meaningful impact in our market, thanks to their high-quality ingredients and well-documented benefits. We are proud to bring Equazen® back to Portugal and will work closely with SFI Health™ EMEA to strengthen confidence in natural solutions among healthcare professionals and consumers."
Brain health supplements are one of the fastest growing segments in the global food supplements market: in Europe, between 2023 and 2030, the market is expected to grow at a compound annual rate of 12.5%, driven by increased awareness of cognitive and mental health.
SFI Health™ EMEA and Equazen® are present in several markets, including Spain, United Kingdom, Switzerland, Poland, Czech, Slovak, the Netherlands, the Nordics and the Baltics. The company aims at further widening Equazen® distribution to unlock the potential sales of the brand and make the most of the growing brain health supplements market.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing.
Guided by the belief in the healing potential of natural products, SFI Health™combines a rigorous pharma-based approach with the benefits of naturally sourced solutions.
An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa.
SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide.
For more information go to sfihealth.com or follow us SFI Health on LinkedIn.
About Eqyon Healthcare Solutions
Eqyon Healthcare Solutions is a customer-focused company dedicated to optimizing healthcare supply chains. By leveraging strategic partnerships and innovative solutions, we help healthcare providers, pharmacies, and institutions improve efficiency, reduce costs, and enhance patient care.
We are committed to addressing the challenges within the healthcare sector through effective, evidence-based solutions. As part of this commitment, we are excited to reintroduce Equazen® to the Portuguese market. Equazen® aligns with our mission to offer natural, scientifically-backed products that promote cognitive health and well-being. In partnership with trusted global brands like Equazen®, we expand access to high-quality, proven solutions that improve lives.
At Eqyon Healthcare Solutions, we aim to be a leading provider of efficient healthcare solutions, continuously transforming challenges into opportunities and ensuring excellence in customer care.
For more information, visit eqyon.eu and follow Eqyon Healthcare Solutions on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226258206/en/
Contacts
For more information
SFI Health™ EMEA
Elisabetta Bianchi
e-mail address: elisabetta.bianchi@sfihealth.com
Eqyon
Nuno Carvalho & CEO
e-mail address: nuno.carvalho@eqyon.eu
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas27.2.2025 17:00:00 EET | Press release
Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research. Initiated in September 2024, the program will map 11 therapeutic areas across Owkin's extensive transatlantic network, with completion expected by May 2025. The data discovered in this program will power Owkin K, Owkin’s software, driving faster discoveries and improving patient outcomes worldwide. Today, valuable healthcare data is siloed within institutions and departments. AI requires consolidated rich and harmonized datasets to drive progress, but this siloing means the data is not always visible or accessible. This program encompasses multiple oncology indications, including non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), breast cancer, prostate cancer, ovarian cancer, pancreatic cancer, and multiple myeloma (MM). The program also covers t
Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East27.2.2025 16:52:00 EET | Press release
Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices to the Middle East. Effective January 1, 2025, Amico Aesthetics has become the sole authorized distributor of the whole Cynosure Lutronic portfolio across its entire network in the Middle East including UAE, KSA, Kuwait, Qatar, Jordan, Iraq, Egypt, Bahrain, Oman and Lebanon. This strategic relationship further strengthens both companies’ presence and commitment to customer excellence in the region's energy-based device industry. A Leading-Edge Alliance This alliance unites Cynosure Lutronic’s innovative technologies with Amico Aesthetics’ robust distribution network and localized expertise, creating a powerful synergy aimed at delivering unparalleled value to aesthetic practitioners and their patients. Together, both companies aim to elevate aesthetic practice standards and results across
Ascend 2025 Goes Global: Riskified’s Leading Ecommerce Fraud Summit to Take Place in Six Cities Worldwide27.2.2025 16:43:00 EET | Press release
Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, is proud to announce the global expansion of Ascend, its premier fraud and risk intelligence summit. Previously held exclusively in the United States, Ascend will now span six major cities across the globe: New York City, London, Melbourne, Shanghai, Tokyo, and São Paulo. This unique event series will bring regional and sector-specific insights and strategies, unveil technological innovation and tools, and showcase success stories and best practices to help merchants approve more ecommerce orders, overcome risk challenges, act decisively, and unlock profitable growth for their businesses. A Global Summit for Global Challenges Ascend 2025 will bring together ecommerce and retail leaders, fraud experts, and payments innovators. Featured speakers across the globe include Andreas Zodhiates, Operations Manager, Payments Fraud at Booking.com; Paul Woosley, Director of Fraud Analytics at Macy's; Pierre-Edouard Potdevin,
Mindbreeze Heralds a New Era of Data Usage with the Insight Workplace27.2.2025 16:02:00 EET | Press release
Mindbreeze, a leading global provider of AI-based knowledge management solutions, is taking company data interactions to the next level with the Insight Workplace. This solution uses AI agents to retrieve relevant information from different data sources in real time, facilitating access to knowledge while simultaneously making it easier to use. Through proactive knowledge management, companies benefit from significant time savings, both for complex tasks and routine processes. They also provide their teams with a better basis for making business-critical decisions. Employees are constantly using different data sources to access important information for processes and decisions. These prevailing data silos make it difficult to unlock the full potential of AI and automation. This is where Mindbreeze comes in with its Insight Workplace. With its intuitive design and a combination of different artificial intelligence methods, the Insight Workplace makes it easy to interact with company dat
AI-RAN Alliance Celebrates its First Anniversary at MWC 202527.2.2025 16:00:00 EET | Press release
The AI-RAN Alliance has rapidly grown to 75 members, spanning 17 countries across the world. Founded at Mobile World Congress (MWC) 2024, the Alliance unites 43 technology companies, 15 academic institutions, seven service providers, six industry associations, and four labs to accelerate AI-RAN (Artificial Intelligence-Radio Access Networks) development and ecosystem adoption. At MWC 2025, the Alliance will showcase ten cutting-edge demos that illustrate AI's transformative impact on wireless networks. “We are thrilled by the remarkable growth of the AI-RAN Alliance,” said Alex Jinsung Choi, Chair of the AI-RAN Alliance and Principal Fellow of SoftBank Corp.'s Research Institute of Advanced Technology. “The collective effort of our members — from academia to industry leaders — is driving innovation at an unprecedented pace, enabling AI-RAN to supercharge 5G and O-RAN, while laying the foundation for AI-native 6G networks. At MWC 2025, our real-world demos will showcase how AI-native RA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom